Inhibikase Therapeutics Inc.
IKT | NASDAQ
$2.31
+$0.11 (+5.00%)
At close: Sep 22, 2026, 4:00 PM ET
$2.31
$0 (0.00%)
After-hours:
Sep 22, 2026, 7:30 PM ET
Market Data
Market Cap $290.47M
Enterprise Value $131.45M
Beta 0.96
Average Volume 739.95K
Shares Outstanding (Diluted) 174.57M
Shares Change YoY 93.95%
Institutional Ownership 66.16%
Exchange NASDAQ
ISIN US45719W2052
Price Performance
Price Change 1M -8.7%
Price Change 3M 17.6%
Price Change 6M 35.0%
Price Change YTD 12.8%
Price Change 1Y 30.9%
Price Change 3Y 76.0%
Price Change 5Y -81.9%
1M CAGR (ann.) -10.9%
1Y CAGR (ann.) 42.9%
5Y CAGR (ann.) -30.2%
All-Time CAGR -43.6%
Valuation
PE Ratio -4.58
Forward PE N/A
PEG Ratio -0.04
Forward PEG -0.75
PS Ratio N/A
Forward PS 580.90
PB Ratio 1.89
P/FCF Ratio -6.75
P/Adj. FCF Ratio -4.61
P/OCF Ratio -9.17
EV/Sales N/A
EV/EBIT -2.11
EV/EBITDA -2.11
EV/FCF -3.05
Earnings Yield -21.8%
FCF Yield -14.8%
Adj. FCF Yield -21.7%
Financial Health
Net Cash $159.02M
Total Debt $0
Cash & Short-Term Investments $159.02M
Total Assets $163.59M
Current Ratio 15.82
Quick Ratio 15.82
Debt / Equity Ratio 0.00
Debt / EBITDA -0.00
Debt / FCF -0.00
OCF / Debt N/A
Interest Coverage 0.00
Altman Z-Score 15.32
Piotroski F-Score 3
Margins & Profitability
Gross Profit Margin 0.0%
Operating Profit Margin 0.0%
EBITDA Margin 0.0%
Net Profit Margin 0.0%
FCF Margin N/A
Adj. FCF Margin N/A
SBC / Revenue 0.0%
SBC Impact (per share) -46.4%
Returns
Return on Assets -37.1%
Return on Equity -42.8%
Return on Invested Capital -42.9%
Return on Capital Employed -42.9%
Return on Tangible Assets -37.1%
Historical Growth (CAGR)
Revenue CAGR 3Y -150.0%
Revenue CAGR 5Y -71.2%
Revenue CAGR 10Y N/A
EPS CAGR 3Y 72.6%
EPS CAGR 5Y 38.3%
EPS CAGR 10Y N/A
FCF CAGR 3Y -50.2%
FCF CAGR 5Y -25.2%
FCF CAGR 10Y N/A
Analyst Forecasts
Analyst Rating Hold
Analyst Count 2
EPS Growth Next 3Y 18.1%
Revenue Growth Next 3Y N/A
Earnings Date Nov 12, 2026
EPS Estimate (next Q) -$0.11
EPS Growth Est (next Q) -15.4%
Revenue Est (next Q) N/A
Revenue Growth Est (next Q) N/A
Fair Value Estimates
Graham Number N/A
Graham Upside N/A
Lynch Fair Value N/A
Lynch Upside N/A
Price Target $6.50
Price Target Upside 195.5%
Cash Flow
Operating Cash Flow $-42.61M
Free Cash Flow $-43.06M
Adj. Free Cash Flow $-63.03M
FCF Per Share -$0.25
OCF Per Share -$0.24
OCF/S Ratio 0.0%
Income Statement
Revenue $0
Gross Profit $0
Operating Income $-65.81M
EBITDA $-62.34M
Net Income $-60.64M
EPS (Diluted) -$0.48
Revenue / Employee N/A
Profit / Employee $-1.73M
Employees 35
Add to Watchlist
Select watchlists to add or remove IKT